Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178906 · ClinicalTrials.gov registry record
Acoustical Properties of Speech as Indicators of Suicidal Risk
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 124
- Enrollment target
NCT00178906: Completed study, sponsored by Vanderbilt University.
NCT00178906 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 124 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00178906 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
Study Summary
This project is focused on acoustical, sound, analysis of speech in order to identify vocal characteristics of speech that are associated with suicidality. Speech samples will be collected from four populations with different mental health status: suicidal, ideational suicidal, depressed and those in remission from depression, (the control group). Speech of subjects will be recorded during routine diagnostic interview sessions. The speech samples will be acoustically analyzed via digital computer algorithms. The acoustical differences among those groups will be determined based on the statistical analysis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 1999-12 |
| Est. Completion | 2008-04 |
What the finished NCT00178906 record still lists
NCT00178906 is an observational study that tracks outcomes without assigning an intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00178906 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00178906 about?
NCT00178906 is a clinical study titled "Acoustical Properties of Speech as Indicators of Suicidal Risk". This project is focused on acoustical, sound, analysis of speech in order to identify vocal characteristics of speech that are associated with suicidality. Speech samples will be collected from four populations with different mental health status: suicidal, ideational suicidal, depressed and those i...
What is the current status of trial NCT00178906?
This trial is currently completed. The enrollment target is 124 participants. The study started on 1999-12. Estimated completion is 2008-04.
Who is sponsoring clinical trial NCT00178906?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia